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Abstract
Transcriptional coregulators control the activity of many transcription factors and are thought to
have wide ranging effects on gene expression patterns. We show here that muscle-specific nuclear
receptor corepressor 1 (NCoR1) knockout mice have rather selective phenotypic changes,
characterized by enhanced exercise endurance due to an increase of both muscle mass and of
mitochondrial number and activity. The activation of selected transcription factors that control
muscle function, such as MEF2, PPARβ/δ and ERRs, underpinned these phenotypic alterations.
NCoR1 levels are decreased in conditions that require fat oxidation resetting transcriptional
programs to boost oxidative metabolism. The capacity of NCoR1 to modulate oxidative
metabolism may be conserved as the knockdown of gei-8, the sole C.elegans NCoR homolog, also
robustly increased muscle mitochondria and respiration. Collectively, our data suggest that
NCoR1 plays an adaptive role in muscle physiology and that interference with NCoR1 action
could be used to improve muscle function.
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Introduction
Transcription factors are key mediators in homeostatic circuits, as they process
environmental signals into transcriptional changes (Desvergne et al., 2006; Francis et al.,
2003). Transcriptional coregulators have recently emerged as equally important modulators
of such adaptive transcriptional responses. The fact that the activity of coactivators and
corepressors is tightly regulated through the spatial and temporal control of their expression
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and activity levels opens hence another avenue to adapt transcription to environmental cues
(Feige and Auwerx, 2007; Rosenfeld et al., 2006; Smith and O'Malley, 2004; Spiegelman
and Heinrich, 2004). Interestingly, many of these coregulators do not operate in isolation,
but are part of large multi-protein complexes, that integrate complex signaling pathways.
The convergence of an elaborate coregulator network on the peroxisome proliferator-
activated receptor (PPAR) coactivator α (PGC)-1α illustrates this principle well, as its
activity depends on several other coregulators, including the steroid receptor coactivators,
NR interacting protein 1 or RIP140, CREB binding protein, p300, protein arginine
methyltransferase 1, general control of amino acid synthesis 5, and SIRT1 (Fernandez-
Marcos and Auwerx, 2011; Handschin and Spiegelman, 2006).
The corepressor (NCoR1) and the silencing mediator for retinoid and thyroid hormone
receptor (SMRT or NCoR2) are also acting as cofactor scaffolding platforms. NCoR1 and
SMRT hardwire corepressor pathways that incorporate several deacetylases [including class
I (HDAC3), class II (HDAC4, 5, 7, and 9) and class III (SIRT1) HDACs], transducin beta-
like 1 (TBL1) and TBLR1, two highly related F box/WD40-containing factors, and the G-
protein-pathway suppressor 2 [reviewed in (Perissi et al., 2010)]. Since germline NCoR1-/-
and SMRT-/- mice are embryonically lethal (Jepsen et al., 2000; Jepsen et al., 2007),
information on the role of these proteins in adult physiology is limited. Studies of mice with
mutations in the NR interaction domains (RIDs) 1 and 2 of SMRT (SMRTmRID), which
solely disrupts its interaction with NRs, indicated that lethality of SMRT-/- mice is caused by
non-NR transcription factors (Nofsinger et al., 2008). Work in 3T3-L1 cells in which
NCoR1 or SMRT expression was reduced by RNA interference, demonstrated that they
repress adipogenesis by inhibiting PPARγ (Yu et al., 2005). In line with this, adipogenesis
was enhanced in mouse embryonic fibroblasts (MEFs) from SMRTmRID mice (Nofsinger
et al., 2008). Interestingly, SIRT1 is also part of the NCoR1/SMRT complex and contributes
to the inhibition of PPARγ (Picard et al., 2004).
Contrary to adipose tissue, the function of NCoR1/SMRT in skeletal muscle has not yet
been established. We here report the generation and characterization of muscle-specific
NCoR1-/- (NCoR1skm-/-) mice, which displayed a remarkable enhanced exercise capacity.
This was the result of increased muscle mass and a muscle fiber type shift towards more
oxidative fibers, coordinated by the induction of genes involved in mitochondrial biogenesis
and function, ensuing from the activation of PPARβ/δ, ERR, and MEF2. Worms with a
muscle-selective knockdown of gei-8, the sole C.elegans NCoR homolog, also had
improved mitochondrial activity. These data combined with the specific reduction in the
expression levels of NCoR1, but not SMRT, in situations of enhanced fat oxidation,
establish NCoR1 as a key physiological regulator of muscle mass and function.
Results
NCoR1skm-/- mice have increased muscle mass
Given the embryonic lethality of germline NCoR1-/- mice [(Jepsen et al., 2000), Suppl.
Table 1], we generated a floxed NCoR1 mouse line in which exon 11 of the NCoR1 gene
(Horlein et al., 1995) was flanked with LoxP sites, priming it for subsequent deletion using
the Cre-LoxP system. These mice, bearing floxed NCoR1 L2 alleles, were then bred with a
skeletal muscle (skm)-specific Cre driver (human α-skeletal actin promoter) (Miniou et al.,
1999) to yield NCoR1skm-/- and NCoR1skm+/+ mice (Suppl. Fig.1). As expected, NCoR1
mRNA expression was significantly decreased in soleus, gastrocnemius and quadriceps and
modestly reduced in the heart muscle of NCoR1skm-/- mice, but not altered in other tissues
(Figure 1A). No compensatory induction of the related co-repressor SMRT/NCoR2 (Chen
and Evans, 1995) was observed (Figure 1A). We also tried to determine NCoR1 protein
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levels in muscle, but failed to detect the endogenous protein with the currently available
NCoR1 antibodies.
NCoR1skm-/- mice were indistinguishable from NCoR1skm+/+ mice upon visual inspection
and no gross organ anomalies were revealed upon autopsy. The relative mass of the soleus
muscle was higher, whereas the mass of the gastrocnemius showed a trend towards an
increase, which did not reach statistical significance (Suppl. Fig. 2A-B). The soleus was also
more intensely red and there were larger sections with reddish color in the gastrocnemius in
NCoR1skm-/- mice (Suppl. Fig. 2C). Body weight evolution and food intake of male
NCoR1skm-/- and NCoR1skm+/+ mice after weaning was comparable both on chow diet (CD)
and on high fat diet (HFD) (Suppl. Fig. 2A and data not shown). On CD, carbohydrate and
lipid profiles were similar, except for LDL cholesterol, which was reduced in NCoR1skm-/-
mice (Figure 1B). In addition to the lower LDL cholesterol on CD, total and HDL
cholesterol levels were also reduced in NCoR1skm-/- mice on HFD (Figure 1B). Furthermore,
glucose edged down (p=0.074) in the wake of similar insulin levels on HFD. The slightly
reduced area under the curve in intraperitoneal glucose tolerance test (IPGTT; Suppl. Fig.
2D) and the delayed recovery from hypoglycemia during intraperitoneal insulin tolerance
test (IPITT; Suppl. Fig. 2E) in mutant mice on HFD, may suggest a discrete improvement in
insulin sensitivity but without a clear impact on glucose tolerance.
Enhanced exercise performance in NCoR1skm-/- mice
We next evaluated energy expenditure by indirect calorimetry and actiometry in CD and
HFD fed mice (Figure 1C and Suppl. Fig. 2F). Total locomotor activity was significantly
higher in NCoR1skm-/- mice. Consistent with this, O2 consumption (VO2) was increased
under both CD and HFD. Interestingly, the NCoR1skm-/- mice displayed a marked decrease
in the respiratory exchange ratio (RER) on a HFD (Figure 1C), indicating an enhanced use
of fat as main energy source. NCoR1skm-/- mice were also more cold tolerant, as they
maintained their body temperature better when exposed to 4°C (Figure 1D).
Exercise performance was strikingly improved in NCoR1skm-/- mice (Figure 1E-F, and
Suppl. Fig. 3A-D). In endurance exercise, NCoR1skm-/- mice ran for a significantly longer
time and distance before exhaustion (Figure 1E, and Suppl. Fig. 3A-B). The increase of the
VO2 values (ΔVO2) during exercise and the maximal ability to utilize oxygen during
exercise (VO2max), which critically determines the endurance performance of skeletal
muscle, was slightly higher in NCoR1skm-/- mice on both CD (Suppl. Fig. 3D and data not
shown) and HFD (Figure 1F). Despite the moderate reduction in NCoR1 mRNA levels in
cardiac muscle of NCoR1skm-/- mice, heart rate, blood pressure, cardiac morphology and
function were not changed (Suppl. Fig. 3E-G and Suppl. Table 2).
NCoR1skm-/- muscle demonstrates increased oxidative capacity
The enhanced exercise capacity, associated with the increase in overall muscle mass and
change in muscle appearance, led us to examine muscle morphology. Upon staining muscles
with hematoxylin/eosin or toluidine blue, not only the diameter of single muscle fibers was
larger, but also the connective tissue between the muscle bundles was less abundant in
NCoR1skm-/- mice (Figure 2A-B and Suppl. Fig. 4A). The increased number of intensely
stained fibers upon succinate dehydrogenase (SDH) and cytochrome oxidase (COX) (Figure
2C-D) staining, further testified of increased mitochondrial activity in the NCoR1skm-/-
gastrocnemius. Two mitochondrial DNA markers, cyclooxygenase 2 (Cox2) and 16S
ribosomal RNA, normalized by genomic DNA markers [uncoupling protein 2 (Ucp2) and
hexokinase 2 (Hk2)] were both significantly higher in NCoR1skm-/- muscle, indicative of
increased mitochondrial content (Figure 3B). This observation was also underscored by
electron microscopy, which revealed more abundant and larger mitochondria with normal
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structure (Figure 3A). Immunohistochemical analysis of the myosin heavy chain (MyHC)
isoforms (Schiaffino et al., 1989) demonstrated a decreased number of the more glycolytic
MyHC2b fibers, with a concomitant increase in the number of more oxidative MyHC2x and
2a fibers in the NCoR1skm-/- gastrocnemius (Figure 3C). This observation was consolidated
by analysis of MyHC isoform mRNAs, which indicated an increased expression of the
mRNAs of MyHC2x and 2a (more oxidative fibers) compared to that of MyHC2b (more
glycolytic) in both NCoR1skm-/- gastrocnemius and quadriceps (Figure 3D). In quadriceps,
but not gastrocnemius, the expression of MyHC1 mRNA was also increased. Finally,
staining of platelet-endothelial cell adhesion molecule (PECAM)-1, an endothelial cell
marker of angiogenesis and tissue vascularization, which contributes to enhanced
myocellular aerobic capacity, also increased in NCoR1skm-/- muscle (Suppl. Fig. 5C).
The control of muscle mitochondria by NCoR1 is conserved in C.elegans
To investigate whether the effects of NCoR1 deficiency are evolutionary conserved, we took
advantage of the power of C.elegans genetics. A protein blast search indicated that gei-8
(GEX interacting protein family member 8) is the only putative NCoR1 homolog in the
C.elegans genome. Further analysis showed that the total amino acid sequence of gei-8 is
43% homologous to mouse NCoR1 and contained conserved SANT (switching-defective
protein 3 (Swi3), adaptor 2 (Ada2), nuclear receptor co-repressor (N-CoR), transcription
factor (TF) IIIB)) domains (34% identical/77% similar for SANT1; 20% identical/57%
similar for SANT2) (Figure 3E). Other important functional domains (Repressor Domain
(RD) and nuclear receptor Interaction Domain (ID)) were also conserved (Figure 3E). Upon
the robust gei-8 knockdown in worms expressing a mitochondrial GFP-reporter driven by
the muscle-specific myo-3 promoter, a striking enlargement of the mitochondria was
observed in body wall muscle (Figure 3F). This result is not due to an indirect effect on
transcriptional activity through the myo-3 promoter because no increase in GFP expression
is observed with another strain carrying the pmyo-3∷GFP reporter (Supp. Fig. 4B). We also
measured O2 consumption in NR350 transgenic worms fed with gei-8 dsRNA. NR350
worms lack rde-1, an essential component of the RNAi machinery encoding a member of
the PIWI/STING/Argonaute family, in all tissues except the body wall muscle in which the
wild-type rde-1 gene has been rescued using the hlh-1 promoter (Durieux et al., 2011).
Consistent with the effects observed in the mouse, also the muscle-specific knockdown of
gei-8 enhanced O2 consumption in these NR350 worms (Figure 3G), suggesting that the
function of gei-8 to control mitochondrial metabolism is conserved through evolution.
NCoR1 negatively correlates with key mitochondrial and myogenic genes
After establishing these striking mitochondrial effects of NCoR1 in mice and worms, we
exploited a complementary systems genetics approach to evaluate NCoR1s molecular
coexpression partners in the mouse (Argmann et al., 2005; Houtkooper et al., 2010).
Expression of NCoR1 in two panels of genetically heterogeneous mice, made by
intercrossing C57BL/6 with C3H/HeJ (the BXH F2 cross), or C57BL/6 with DBA/2J (the
BXD genetic reference population) mice, varied ±1.5-fold between cases in both lung and
muscle (Figure 4A). A large number of transcripts covaried significantly with NCoR1 in the
different mice lines belonging either to the BXH cross or BXD strains. Most distinctively,
only a fraction of these covariates were negative, which was against the dogma expected for
a corepressor such as NCoR1s (Suppl. Tables 4 and 5). In skeletal muscle from the BXH
cross (n=124 females), strong covariates of NCoR1 include myocyte-specific enhancer
factor 2D (Mef2d), myoglobin (Mb), muscle creatine kinase (Mck), and glucose transporter
type 4 (Glut4) (van Nas et al., 2010). A similar analysis of lung tissue from the BXD cross
(n=51 strains) includes genes such as cytochrome c (Cycs), citrate synthase (Cs), pyruvate
dehydrogenase kinase 4 (Pdk4), uncoupling protein 3 (Ucp3), vascular endothelial growth
factor b (Vegfb), and long chain acyl-CoA dehydrogenase (Lcad) (Schughart and Williams,
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unpublished data) (Figure 4B and Suppl. Table 4 and 5). This analysis significantly extends
the number of NCoR1 targets and covariates, with several of them being consistent with
increased mass and mitochondrial biogenesis observed in NCoR1skm-/- muscle.
This initial set of NCoR1 covariates (Figure 4B) was then included together with other
potential candidates for qRT-PCR analysis in mixed fiber muscle, including the
gastrocnemius and quadriceps (Figure 4C, Suppl. Fig. 5A, data not shown). Whereas the
mRNAs of most relevant NRs were unchanged, mRNA levels of PGC-1α and β (Ppargc1a
and 1b) increased. Several genes involved in mitochondrial function, including those
encoding for proteins involved in TCA cycle and oxidative phosphorylation [Cs,
cytochrome c oxidase subunit IV (CoxIV), Pdk4], uncoupling [Ucp2 and Ucp3], fatty acid
uptake and metabolism [Cd36 and Lcad], were robustly induced in NCoR1skm-/- muscle. In
addition, mRNA levels of Vegfb and its receptor Flt1, which regulates trans-endothelial fatty
acid transport (Hagberg et al., 2010), were also induced. Interestingly, the expression of
hypoxia inducible factor (Hif) 1α and of its targets, glucose transporter 1 (Glut1), fibroblast
growth factor (Fgf) and Fgf-receptor 2 (Fgfr2), were unchanged (Suppl. Fig. 5A), whereas
all three Vegfa isoforms, i.e. Vegfa-121, -165, and -189, were induced in NCoR1-/-
quadriceps, gastrocnemius, and soleus (Figure 4C, Suppl. Fig. 5B). Together with this
increase in Vegfa, both Angpt2 and Pdgfb mRNA levels were induced (Figure 4C),
suggesting that myocellular aerobic capacity is facilitated by a HIF1α-independent
angiogenic pathway in NCoR1skm-/- mice (Arany et al., 2008).
Enhanced PPARβ/δ and/or ERR function in NCoR1skm-/- muscle
Several genes whose expression is changed in the absence of NCoR1 are PPARβ/δ and/or
ERR targets (Figure 4). Since the expression of PPARβ/δ and/or ERR was unchanged in
NCoR1skm-/- mice (Suppl. Fig. 5A), a direct effect of NCoR1 on the expression of these
targets through the activation of these NRs was expected. As cases in point to demonstrate
the recruitment of NCoR1 to these genes, we selected the mouse Ucp3 and Pdk4 promoters,
which contain three PPAR responsive elements (PPREs) (Figure 5A) and extended NR half-
sites (NR1/2), known to bind members of the ERR subfamily (Figure 5E) (Zhang et al.,
2006), respectively. We first used NIH-3T3 cells in which an epitope-tagged version of
NCoR1 (NCoR1-FLAG) was expressed. The two PPREs adjacent to the Ucp3 transcription
start site recruited NCoR1 more efficiently, compared to two control sequences in the
Gapdh and Ucp3 promoter that lack PPREs (Figure 5B, left). Likewise, NCoR1 bound
avidly to the mouse Pdk4 promoter NR1/2 site in transfected NIH-3T3 cells (Figure 5F,
left). Although there is a two nucleotide difference in NR1/2 site of the human Pdk4
promoter (Figure 5E), NCoR1 and ERRα were also recruited to this site in human HEK293
cells (Figure 5H).
We then used a highly specific NCoR1 antibody, which we recently generated (Barish &
Evans, unpublished), for ChIP experiments in C2C12 myotubes. Confirming our data in
NIH-3T3 cells that express NCoR1-FLAG, endogenous NCoR1 occupied the same Ucp3
PPREs (Figure 5B, right). The recruitment of NCoR1 to the Ucp3 promoter was robustly
inhibited by the addition of the selective PPARβ/δ ligand GW501516. Likewise,
endogenous NCoR1 was readily detected on the NR1/2 in the Pdk4 promoter in C2C12
myotubes (Figure 5F, right).
Subsequently, we explored whether NCoR1 gene deletion in NCoR1L2/L2 MEFs by means of
adenoviral Cre recombination, or NCoR1 gene knockdown in C2C12 myotubes infected by
an NCoR1 shRNA adenovirus, modulates histone H4 acetylation on the Ucp3 and Pdk4
promoters. Consistent with NCoR1 binding to these promoters in NIH-3T3 cells and C2C12
myotubes (Figure 5B and F), NCoR1 deletion or silencing induced H4 acetylation of both
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target promoters in MEFs and C2C12 cells, indicating chromatin opening (Figure 5C and
G).
To further consolidate these observations, we analyzed whether NCoR1 interacts directly
with PPARβ/δ or ERRα, using nuclear extracts of HEK293 cells, transfected with tagged
versions of NCoR1, PPARβ/δ or ERRα. Although a specific association between NCoR1
and PPARβ/δ was evident in these co-IP experiments (Figure 5D, lane 8), we failed to detect
a similar interaction between ERRα and NCoR1 (data not shown).
MEF2 is hyperacetylated and activated in the absence of NCoR1
The increased muscle mass observed in NCoR1skm-/- mice indicated that the absence of
NCoR1 not only induced oxidative metabolism, but also stimulated myogenesis. In line with
this, mRNA levels of two markers of myogenesis, Mb and Mck were increased in
NCoR1skm-/- quadriceps (Figure 6A). Amongst several myogenic regulatory factors, only the
expression of two Mef2 family members, i.e. Mef2c and Mef2d, negatively correlated with
NCoR1 expression in our systems genetics analysis (Figure 4 and Suppl. Fig. 6A). The
selective induction of Mef2c and Mef2d mRNA was furthermore confirmed by qRT-PCR of
NCoR1skm-/- gastrocnemius and quadriceps, while no changes were found in MyoD, myf5,
and myogenin mRNA (Figure 6A, Suppl. Fig. 6E, data not shown).
The activity of MEF2 family members is not only controlled by their expression levels, but
is also modulated by their acetylation status. MEF2 is acetylated and activated by p300,
whereas it is deacetylated by HDAC3 and HDAC4, which are part of the NCoR1
corepressor complex (Ma et al., 2005; Nebbioso et al., 2009). Since the expression of the
Mef2d isoform is most prominently correlated with NCoR1 expression, we investigated
MEF2D acetylation in gastrocnemius and found that its acetylation levels were enhanced in
NCoR1skm-/- mice (Figure 6A-B).
We then compared the acetylation of MEF2D in floxed NCoR1L2/L2 MEFs, infected with an
adenovirus expressing either GFP as control or Cre-recombinase to reduce NCoR1 protein
expression (Figure 6C, left panel). Whereas MEF2D protein levels were stable in NCoR1-/-
MEFs, perhaps due to the more acute nature of the deletion, MEF2D was robustly
hyperacetylated when NCoR1 levels were attenuated (Figure 6C, right panel). Likewise, a
slight but consistent MEF2D hyperacetylation was observed in C2C12 myotubes infected
with Ad-shNCoR1 to knockdown NCoR1 expression (Figure 6D and Suppl. Fig. 6B-D),
further underscoring the importance of MEF2D deacetylation by the NCoR1 complex.
Given the induction of MEF2D expression and its hyperacetylation and consistent with our
systems genetics analysis (Figure 4B), mRNA levels of the MEF2 targets, Mb and Mck,
were robustly induced in NCoR1skm-/- gastrocnemius (Figure 6A). Silencing of NCoR1 in
C2C12 myotubes also resulted in a similar induction of several MEF2 target genes,
including Mb, Mck, Glut4, c-jun, Nur77, PGC-1α, PGC-1β (Figure 6E and Suppl. Fig. 6B-
D). In line with these data, endogenous NCoR1 was readily detected on MEF2 binding sites
on these target promoters in C2C12 myotubes, as illustrated for the Mb promoter (Figure
6F). The induction of these MEF2 targets by NCoR1 knock-down was furthermore
accompanied by H4K16 and global H4 hyperacetylation on their promoters (e.g. Mb, Glut4,
Mck) (Figure 6G and Suppl. Fig. 6F).
NCoR1 levels are regulated in response to physiological stimuli
We next investigated whether NCoR1 function could be altered by different physiological
stimuli in vitro and in vivo. One hour after stimulation of 293T cells with 1 μM insulin,
higher amounts of endogenous NCoR1 (Figure 7A) or transfected FLAG-NCoR1 (Suppl.
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Fig. 7A) were detected in nuclei as evidenced by immunofluorescence and subcellular
fractionation (Figure 7A-C).
At the transcriptional level, NCoR1 mRNA changed in response to different concentrations
of glucose in the culture media (Figure 7D-E). Growing MEFs in low glucose decreased
NCoR1 mRNA (Figure 7D) and protein (Figure 7E) levels, concomitant with the induction
of its target genes (Pdk4, Vgefb, Mef2d, etc.). Similar results, i.e. decreased mRNA levels of
NCoR1 associated with increased expression of its targets (Pdk4, Ucp2, Ucp3, Vegfb, Mb,
Mck, Glut4), were also obtained in glucose-deprived C2C12 myotubes (Suppl. Fig. 7B).
Interestingly, the reduction of glucose decreased mRNA levels of NCoR1, but not those of
SMRT (Figure 7F). The tight dose-dependent correlation between NCoR1 expression and
glucose levels in the culture medium (Figure 7E-F), suggested the possibility that NCoR1
could block the oxidation of lipid substrates when glucose was available. We therefore
evaluated NCoR1 mRNA and protein in MEFs cultured in different fatty acid concentrations
(Figure 7H-I). The addition of oleic acid (OA) to the medium to force fatty acid oxidation
also decreased NCoR1 levels, independently of the glucose concentration (Figure 7H). These
effects seemed again specific to NCoR1, as only a small difference in SMRT mRNA levels
was observed with OA in the absence of glucose (data not shown). Together, these data
indicate that settings that favor fatty acid oxidation (i.e. low glucose, low insulin, and high
fatty acid) are all associated with a reduction of NCoR1.
We then test whether different conditions that enhance fatty acid oxidation also modulate
NCoR1 mRNA levels in the muscle in vivo. This was indeed the case, as muscle NCoR1, but
not SMRT, mRNA levels decreased after exercise (3 hrs after a resistance run), high fat
feeding (20 wks of high fat feeding), fasting (after a 16 hr fast), and aging (6-mo vs 2-yr-old
mice) (Figure 7J, data not shown). Interestingly, the reduction in NCoR1 mRNA levels
match well with the potentiation of lipid oxidation after exercise (Kiens and Richter, 1998;
Pilegaard et al., 2000), high fat feeding (Watanabe et al., 2006), fasting (Storlien et al.,
2004) and in aged mice (unpublished data R. Houtkooper and J. Auwerx). Also in
epidydimal white adipose tissue, HFD feeding reduced specifically NCoR1, and not SMRT,
mRNA (Suppl. Fig. 7C). Unlike for the muscle, where we were unable to detect NCoR1
with the available antibodies, NCoR1 protein levels almost disappeared from epidydimal fat
upon HFD (Suppl. Fig. 7D). Altogether, these data led us to suggest that NCoR1 is a
negative transcriptional regulator of fatty acid oxidation and that a reduction of NCoR1
enables the muscle (and adipose tissue), to deal with lipid substrates more efficiently.
Discussion
The increased muscle mass, associated with a strikingly improved exercise capacity, is the
most prominent phenotypic outcome of the muscle-specific NCoR1 gene deletion. The
enhanced exercise capacity is associated with a reprogramming of glycolytic to more
oxidative muscle fibers and a corresponding stimulation of oxidative mitochondrial
metabolism, indicative of an improved intrinsic quality of the muscles. The increased
muscle quantity and oxidative profile in NCoR1skm-/- mice also contributes to the slight
improvement in metabolic parameters after high fat feeding and to the cold resistance
subsequent to shivering thermogenesis (Canto and Auwerx, 2009).
Combined these properties suggest that NCoR1 acts as a master modulator of mitochondrial
metabolism in the muscle, a hypothesis bolstered by the fact that the inhibition of the single
worm NCoR homolog, gei-8, also robustly boosts muscle oxidative mitochondrial
metabolism in C. elegans. The evolutionary conservation of the structure and function of
this corepressor makes it tempting to speculate that NCoR may have evolved to facilitate
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metabolic adaptation of the mitochondria to energy availability, as has been described for
other cofactors as SIRT1 (Canto and Auwerx, 2009).
As to how the absence of NCoR1 in the muscle achieves these remarkable effects, it is
important to recall that NCoR1 docks histone deacetylases, such as HDAC3 (Alenghat et al.,
2008) and SIRT1 (Picard et al., 2004). The use of mice with a point mutation in the NCoR1
deacetylase activation domain, incapacitating its interaction with HDAC3, indicated that this
interaction is a nodal point in epigenetic regulation (Alenghat et al., 2008; Feng et al., 2011).
The physiological alterations in the NCoR1skm-/- muscle together with the study of the
expression correlates of NCoR1 suggested that, rather than the generalized transcriptional
activation expected upon ablation of a corepressor platform protein, only a small set of
transcriptional pathways was selectively affected.
Several transcription factors control muscle differentiation and development, including
MyoD, myogenin, Myf5, Myf6, and MEF2 (Black and Olson, 1998; McKinsey et al., 2001,
2002; Potthoff and Olson, 2007). MEF2 especially caught our attention, as only its
expression negatively correlated with NCoR1 (Figure 4B and Suppl. Fig. 10) and was
induced in NCoR1skm-/- muscle (Figure 6A). MEF2 is key for muscle development, and also
participates in muscle stress-response and remodeling in adulthood, such as occurs during
muscle fiber type switch (Potthoff and Olson, 2007; Zhang et al., 2002). MEF2 activity is
not only controlled at the level of its expression, but also by a wide range of intracellular
signaling pathways and interacting co-regulator molecules [reviewed by (Potthoff and
Olson, 2007)]. The histone acetyltransferase s, p300/CBP bind, acetylate, and activate
MEF2 (Ma et al., 2005; McKinsey et al., 2001), whereas Class I [HDAC3 (Gregoire et al.,
2007)], Class II [HDAC4, 5, 7, and 9 (Haberland et al., 2007; McKinsey et al., 2001)], and
class III HDACs [SIRT1 (Zhao et al., 2005)] all are reported to interact with MEF2 and
prevent the activation of its target genes (McKinsey et al., 2001). The absence of NCoR1
would hence favor the acetylation and activation of MEF2. The hyperacetylation of MEF2D
and histone 4 in NCoR1 deficient MEFs, C2C12 myotubes, and muscles, which translates
into the induction of MEF2 targets and the gain of muscle mass in NCoR1skm-/- mice, is fully
in line with this idea (Figure 6).
The increased expression of genes related to fatty acid catabolism and mitochondrial
respiration, underlie the oxidative mitochondrial changes observed in the NCoR1skm-/- mice.
In the muscle, the expression of these gene sets is tightly controlled by NRs belonging to the
PPAR and ERR families (Alaynick, 2008). PPARβ/δ, the predominant PPAR isoform in
oxidative fibers, regulates oxidative capacity and enhances slow fiber-type function,
resulting in improved exercise capacity and metabolic protection (Luquet et al., 2003;
Tanaka et al., 2003; Wang et al., 2004). Amongst the ERRs, mainly ERRα and ERRγ seem
to be involved in the coordination of muscle energy homeostasis [reviewed in (Giguere,
2008; Villena and Kralli, 2008)]. In line with this, a genome-wide location analysis of ERRα
and ERRγ identified binding sites in genes of a large number of mitochondrial proteins
(Dufour et al., 2007), and studies in mouse models show that they coordinate many aspects
of muscle oxidative metabolism, including endurance capacity (Giguere, 2008; Narkar et al.,
2011; Villena and Kralli, 2008). Several features of the NCoR1skm-/- mice are suggestive of
the activation of PPARβ/δ and ERR. The demonstration that NCoR1 is recruited to the
PPREs in the Ucp3 and the NR1/2 in Pdk4 promoters and that histone 4 is hyperacetylated
on these promoters when NCoR1 is absent, suggests that coactivators now activate the
transcription of these genes in a fashion unopposed by the NCoR1 corepressor platform
(Figure 7K). Given that PGC-1α is a key coactivator of PPARβ/δ and ERR transcriptional
programs [reviewed in (Handschin and Spiegelman, 2006)], it is also no surprise that several
phenotypic features, ranging from similarities in gene expression patterns over the induction
of mitochondrial oxidative metabolism and exercise capacity to HIF1α-independent
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angiogenesis, are shared between mice that lack NCoR1 or that overexpress PGC-1α (Arany
et al., 2008; Lin et al., 2002).
NCoR1 action is tightly regulated by various physiological challenges and this is achieved
through, at least, two different mechanisms. First, nuclear levels of NCoR1 are regulated.
Our results show how insulin, which stimulates glucose oxidation at the expense of fatty
acid oxidation, increases NCoR1 levels in the nucleus, enabling it to subsequently repress
lipid oxidation genes. Interestingly, this effect of insulin on nuclear NCoR1 accumulation, is
consistent with the positive effect of mTORC1 on nuclear NCoR1 accumulation, recently
reported in hepatocytes (Sengupta et al., 2010). The second mechanism involves the
modulation of NCoR1 expression. Exposing cells to media with low glucose and/or high
fatty acid levels, reduces specifically NCoR1 (but not SMRT) mRNA and protein levels,
ultimately de-repressing genes that control oxidative lipid metabolism. Likewise, endurance
exercise, fasting, high fat feeding and aging, conditions paired with increased fat oxidation,
also are characterized by attenuated muscle NCoR1 mRNA expression. Although we are
unable to detect NCoR1 protein in the muscle with the currently available antibodies, our
data in adipose tissue unequivocally show that the specific reduction in NCoR1 mRNA
observed in that tissue after HFD is matched with a spectacular drop in NCoR1 protein. If
the reduced NCoR1 mRNA levels in muscle also translate in corresponding changes in
NCoR1 protein, they will prime the muscle for mitochondrial oxidation. These selective
effects of NCoR1 to repress muscle fatty acid oxidation, hence suggest that changes in
NCoR1 levels adapt transcriptional outcomes to physiological energy needs (Figure 7K).
In conclusion, we demonstrated here that NCoR is an evolutionary conserved negative
regulator of both muscle mass and mitochondrial oxidative metabolism in nematode and
mammals. In the mouse, NCoR1 achieves these effects through controlling a rather selected
set of functional pathways, which are governed by MEF2, PPARβ/δ and the ERRs. The
NCoR1skm-/- muscle phenotype furthermore mirrors many features of the stimulation of
PGC-1α, a coactivator, whose action is less constrained by the absence of the NCoR1
corepressor scaffold. Our work also provides evidence that NCoR1 expression is regulated
in a dynamic fashion and as such could play a role, similar to PGC-1α, in transcriptional
adaptation to physiological challenges. Moreover, pharmacological inhibition of NCoR1
and/or its interaction with deacetylases may be a viable approach to improve muscle mass
and oxidative metabolism. The fact that the inhibition of HDACs increases muscle cell size
supports this concept (Iezzi et al., 2004). It is also tempting to speculate that the beneficial
effects of the inhibition of mTORC1 and insulin signaling on health- and life-span, may in
part rely on the attenuation of NCoR1 activity and the subsequent induction of oxidative
metabolism in the muscle [reviewed in (Houtkooper et al., 2010)].
Experimental Procedures
Animal studies
NCoR1 floxed (NCoR1L2/L2), NCoR1skm+/+ and skm-/- mice were generated at the Mouse
Clinical Institute (Strasbourg, France) and phenotyped (Champy et al., 2004; Champy et al.,
2008) according to standard procedures that are described in detail in the Suppl. Materials.
C. elegans strains, RNAi feeding experiments, GFP expression analysis are described in the
Suppl. Materials. C.elegans O2 consumption was measured in 200 two-day old worms using
a Seahorse XF24 as described in the Suppl. Materials.
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Histological and EM analyses
Staining of muscles with hematoxylin/eosin, immunohistochemical and EM analysis,
analysis of enzymatic activity of SDH and COX was carried out as described (Lagouge et
al., 2006).
mRNA analysis and identification of NCoR1-correlated genes
The mRNA expression levels were measured in cells and tissues using qRT-PCR (Lagouge
et al., 2006) The GeneNetwork program (http://www.genenetwork.org) was used to generate
a broad range of NCoR1-correlated genes that may contribute to the phenotype of
NCoR1skm-/- mice. Skeletal muscle mRNA expression was analyzed using 124 females from
a classic F2 intercross between C57BL/6J and C3H/HeJ [UCLA BHHBF2 Muscle; (van Nas
et al., 2010); GEO GSE12795]. NCoR1 (10024414685, 3′ UTR) was compared across all
transcripts to find muscle covariates. Lung mRNA in a recombinant inbred intercross
between C57BL/6J and DBA/2J was analyzed across 51 strains [HZI BXD Lung M430v2
(Apr08) RMA; (Alberts et al., 2011)]. Four NCoR1 probe sets from this microarray were
analyzed (1423200_at, 3′ UTR; 1435914_at, 3′ UTR; 1423202_a_at, exonic and 3′ UTR;
1423201_at, exonic). For all probe sets, the top correlates were calculated (Suppl. Tables 4,
5). Strong or interesting correlates were selected for validation by qRT-PCR.
Cell culture, adenoviral infections, ChIP, co-IP, and Western blot experiments
Experimental details are provided in the Suppl. procedures.
Statistical Analyses
Statistical analyses were performed with a Student's t test for independent samples. Data are
expressed as mean ± SEM, and p values smaller than 0.05 were considered as statistically
significant. Statistical significance is displayed as * (p < 0.05), ** (p < 0.01), or *** (p <
0.001).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Validation and metabolic phenotypes of NCoR1skm-/- mice
(A) mRNA levels of NCoR1 and Smrt in different tissues were determined by qRT-PCR.
Values were normalized to 36B4. (n=8-10/group). (B) Biochemical analysis of the plasma
from NCoR1skm+/+ and skm-/- mice after 6 hr fasting (n=8) either on chow diet (CD) (top) or
HFD (bottom). (C) Circadian activity, measured as the total locomotor activity, and energy
expenditure was evaluated by the measurement of oxygen consumption (VO2), and by the
calculation of the respiratory exchange ratio (RER) over a 24 hr period after 12 wks of HFD.
The bar graphs represent the average for each group (n = 12). (D) Body temperature was
measured for 7 hr in mice exposed to 4°C after 18-wks of HFD (n=7, 8). (E and F) Exercise
experiments, measuring running time and distance till exhaustion (endurance exercise) (E)
and the increment of VO2max, during exercise, and RER levels at basal and VO2max
condition (F) were performed after 14- and 17-wk HFD.
Data are expressed as mean ± SEM.
See also Suppl. Figs. 1-3 and Suppl. Tables 1-3.
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Figure 2. Histological analyses of the muscles of control and NCoR1skm-/- mice
(A) Histological analysis of gastrocnemius sections stained with H&E. (B) Distribution and
mean diameter of muscle fibers in gastrocnemius and soleus. (C and D) Histological
analysis of gastrocnemius and soleus sections by succinate dehydrogenase (C) and
cytochrome C oxidase staining (D). (C). S, soleus; G, gastrocnemius. The ratio of the stained
fibers is indicated in the graph.
Data are expressed as mean ± SEM.See also Suppl. Fig. 4.
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Figure 3. Histological analyses of the muscles of mice and C. elegans
Transmission electron microscopy of non-oxidative fibers of NCoR1skm+/+ and skm-/-
gastrocnemius. M, mitochondria. (B) Relative mitochondrial DNA content (Cox2 or 16S) in
gastrocnemius was measured and normalized by genomic DNA content (Ucp2 and Hk)
(n=6). (C) Representative MyHC1, 2a, and 2b immunohistochemical detection on serial
sections of the soleus and gastrocnemius. (D) Subtypes of MyHCs in gastrocnemius and
quadriceps were analyzed by qRT-PCR in NCoR1skm+/+ and skm-/- mice (n=6). (E) Indentity/
similarity (%) in the sequences of gei-8 with mammalian NCoR1. Multiple alignment of
SANT domains of NCoR1 homologs. Color identifies similarity. (F) Representative pictures
of the effects of RNAi-mediated knockdown of gei-8 on mitochondrial morphology and
number in a C.elegans strain carrying a mitochondrial GFP-reporter driven by the muscle-
specific myo-3 promoter (left panel). Quantification of the mitochondrial induction by
fluorescence upon gei-8 knockdown (middle panel), and of the efficacy of the RNAi-
mediated gei-8 knockdown by qRT-PCR analysis (right panel). (G) Muscle-specific RNAi
inhibition of gei-8 enhances respiration in C.elegans.
Data are expressed as mean ± SEM.
See also Suppl. Fig. 3 and Suppl. Tables 2 and 3.
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Figure 4. Identification of NcoR1-correlated genes
(A) Expression of NCoR1 mRNA in lung tissue of the different BXD strains (upper) and in
muscle tissue from an F2 intercross between C57BL/6J and C3H/HeJ (lower panel). Natural
expression variation across the animals is ∼1.5 fold in each tissue. (B) Pearson's r and
Spearman's rank correlation coefficient, rho, were calculated with corresponding p values
for the mRNA covariation between NCoR1 and genes involved in oxidative phosphorylation
(Cycs, Cs, and Pdk4), mitochondrial uncoupling (Ucp3), fatty acid metabolism (Lcad),
angiogenesis (Vegfb), glucose uptake (Glut4), and myogenesis (Mef2d, Mb, Mck). The tissue
from which data were generated is indicated. (C) Gene expression analysis by qRT-PCR in
NCoR1skm+/+ and skm-/- gastrocnemius (n=10).
Data are expressed as mean ± SEM.See also Suppl. Fig. 5 and Suppl. Tables 3-5.
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Figure 5. Increased PPARβ/δ and ERR activity in NCoR1skm/- muscle
(A, B, E, F, and H) NCoR1 recruitment to the PPREs on mouse Ucp3 promoter and to the
ERR-RE on human and mouse Pdk4 promoter determined by ChIP in NIH-3T3 cells
transfected with an NCoR1-FLAG vector or in C2C12 myotubes. A schematic of the
promoters of the Ucp3 (A) and Pdk4 (E) genes and the sequence alignment of the mouse, rat
and human Pdk4 promoter is also shown to highlight the conservation of the NR1/2 (or
ERR-RE) (E). Boxes indicate putative PPREs in the Ucp3 and the NR1/2, IRS, and Sp1 in
the Pdk4 promoter. ChIP experiments for the Ucp3 promoter were performed in C2C12
myotubes both before and 6 hr after addition of a PPARβ/δ agonist (100 nM GW501516). #;
not detected. ChIP experiments in HEK293 cells transfected with FLAG-NCoR1 and HA-
ERRα vector (H). (C and G) Binding of acetylated histone 4 (H4) to the PPREs on the Ucp3
and to the NR1/2 on the Pdk4 promoters in ChIP assays, using either immortalized
NCoR1L2/L2 MEFs, infected with an adenovirus either expressing GFP or Cre recombinase,
or C2C12 myotubes infected with the Ad-shNCoR1 virus. Representative data is shown
from 3 experiments. (D) Interaction between PPARβ/δ and NCoR1 determined by in vitro
co-IP experiments from HEK293 cells, in which NCoR1-FLAG and/or V5-PPARβ/δ are
expressed. IP was performed with control IgG (lanes 1, 3, 5, and 7) or anti-FLAG antibody
(lanes 2, 4, 6, and 8) and the immunoblot was developed with an anti-V5 antibody. PPARβ/δ
co-immunoprecipitated by the anti-FLAG antibody is indicated by an arrow. Input samples
are shown in lanes 9 -12.
Data are expressed as mean ± SEM.
See also Suppl. Fig. 6.
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Figure 6. Enhanced MEF2 activity in NCoR1skm-/- muscle
(A) Gene expression of myogenesis-related genes was measured by qRT-PCR in
NCoR1skm+/+ and skm-/- quadriceps (n=10). (B, C, and D) Acetylation levels of MEF2D
were determined by Western blot after immunoprecipitation with an Ac-Lys Ab from
gastrocnemius (B), from NCoR1L2/L2-MEFs infected with Ad-GFP or Ad-Cre recombinase
(C, right), and from C2C12 myotubes infected with Ad-shLacZ or Ad-shNCoR1 (D).
MEF2D expression in total protein extracts was shown in the lower panels. The expression
of NCoR1 and actin in NCoR1L2/L2-MEFs was also shown (C, left). (E) MEF2 target
mRNAs determined by qRT-PCR in C2C12 myotubes infected with either Ad-shLacZ or
Ad-shNCoR1 (n=6). (F) NCoR1 recruitment to the MEF2 site of the mouse Mb promoter
determined by ChIP in C2C12 myotubes. (G) Binding of either global acetylated histone 4
(H4) or H4 acetylated on K16 (H4K16) to the MEF2 site of the Mb gene was evaluated by
ChIP from C2C12 myotubes infected as in (E). Data are expressed as mean ± SEM.
See also Suppl. Fig. 6 and Suppl. Table 3.
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Figure 7. Localization and expression of NCoR1 in physiological condition
(A-C) Localization of NCoR1 protein was determined either by immunofluorescence and
quantified (A and B) and by western blot (C). 293T cells grown without (-) or with (+) 1 μM
insulin for 1 hr were stained by DAPI or anti-NCoR1 (A). Quantification of nuclear NCoR1
is shown in (B). Nuclear and cytosolic fractions were separated from FLAG-NCoR1
transfected 293T cells after a 1 hr-stimulation without (-) or with 1 μM insulin (+) and
protein levels were determined by western blotting (C). (D) mRNA levels of NCoRs and its
target genes determined by qRT-PCR in MEFs cultured for 24 hr in 5 or 25 mM glucose
(n=6). (E) NCoR1 protein was determined by western blotting from MEFs cultured for 24 hr
in 5 or 25 mM glucose. (F) NCoR1 and SMRT mRNA was determined in MEFs cultured for
48 hr in 0, 5, and 25 mM glucose. (G) NCoR1 protein was determined by western blotting
from MEFs cultured for 24 hrs in 0, 5, or 25 mM glucose. (H) NCoR1 mRNA expression in
MEFs grown for 48 hr in 0 mM glucose with or without 0.03 mM oleic acid (n=4). (I)
NCoR1 protein determined by western blotting from MEFs cultured as indicated in (G). (J)
NCoR1 mRNA measured by qRT-PCR in muscles of resting mice or 3 hrs after an
endurance run (14-wk old; n =5), in mice that were fed for 20 wks either with HFD or CD
(28-wk old; n=8), in mice that were fasted or fed for 16 hrs (14-wk old; n=10), and in 6-
month or 2-year old mice (n=10). (K) Model schematizing how different levels of NCoR1
controls transcription of muscle genes by controlling the activity of transcription factors
(TFs; i.e. PPARβ/δ, ERR, and MEF2).
Data are expressed as mean ± SEM.
See also Suppl. Fig. 7 and Suppl. Table 3.
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